PAR 3.92% 24.5¢ paradigm biopharmaceuticals limited..

PAR CEO explains SAS patient results in interview, page-22

  1. 5,970 Posts.
    lightbulb Created with Sketch. 1150
    helts, or mozz, anyone,

    no news on whether pay for SAS will be recorded for more ongoing patient results? i.e. just a thought that it may be reserved for patients that are being treated for the first time so they can keep tracking patient results? But, then again, may also be open for anyone willing to part with their cash regardless... have you spoken with physician or company helts?

    hopeless for you helts a booster is obtainable
    Last edited by oxxa23: 08/02/21
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.010(3.92%)
Mkt cap ! $85.70M
Open High Low Value Volume
24.5¢ 25.0¢ 24.0¢ $59.66K 241.2K

Buyers (Bids)

No. Vol. Price($)
4 78837 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 36290 1
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.